São Paulo Seeks Volunteers for New Injectable Anti-HIV Drug

Cabotegravir injections are an alternative to a daily cocktail and may be the first step in the evolution of daily oral prophylaxis due to its long-lasting discretion and convenience. Tests will be performed on HIV-negative individuals.

By Xiu Ying, Contributing Reporter

SÃO PAULO, BRAZIL - The government of the state of São Paulo is seeking volunteers to test a new drug preventing HIV infection, the cause of AIDS, using long-term injections as an alternative to the daily oral cocktail.

To date, the only approved method of preventing the virus from spreading is the scheduled use of a combination of tenofovir and emtricitabine tablets. This pre-exposure prophylaxis (PrEP) has been available at SUS since 2018 and has proven effective in controlling the epidemic in different cities around the world.

However, Cabotegravir injections could be . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?